Please use this identifier to cite or link to this item:
|Title:||Recent Advances in the Molecular Modeling of Estrogen Receptor-Mediated Toxicity|
|Authors:||TSAKOVSKA Ivanka; PAJEVA Ilza; ALOV Petko; WORTH Andrew|
|JRC Publication N°:||JRC63851|
|Type:||Articles in books|
|Abstract:||In the past two decades there has been increasing concern about the potentially adverse effects of exogenous Endocrine Active Substances (EAS) that alter the function of the endocrine system by interfering with hormone regulation. The mechanistic pathways by which EAS may elicit adverse effects, such as developmental and reproductive toxicity, often involve direct binding to nuclear hormone receptors. Certainly the best studied nuclear receptor is the estrogen receptor. Large-scale in vitro and in vivo methods have been developed to assess the estrogenic toxicity of chemicals. However there are financial and animal welfare concerns related to their application. QSAR (Quantitative Structure-Activity Relationship) approaches have proven their utility as a priority setting tool in the risk assessment. In addition the models help to clarify the binding mode of the interacting substances. Since the estrogen mediated effects are usually related to ligand-receptor interactions, and since there have been comprehensive structural studies on the estrogen receptor, molecular modelling (in silico) approaches provide a suitable means of studying these estrogenic effects. This chapter provides an overview of the molecular modelling approaches applied to ligand - estrogen receptor interactions. The progress in the field is outlined and some critical issues are analysed based on recently published models where these approaches are applied.|
|JRC Institute:||Institute for Health and Consumer Protection|
Files in This Item:
There are no files associated with this item.
Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.